Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?

Item

http://www.wikidata.org/entity/Q36621336

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Does gap-free intensity modula ...... in patients with anal cancer?

@ast

Does gap-free intensity modula ...... in patients with anal cancer?

@en

type

Item

label

Does gap-free intensity modula ...... in patients with anal cancer?

@ast

Does gap-free intensity modula ...... in patients with anal cancer?

@en

prefLabel

Does gap-free intensity modula ...... in patients with anal cancer?

@ast

Does gap-free intensity modula ...... in patients with anal cancer?

@en

P1476

Does gap-free intensity modula ...... in patients with anal cancer?

@en

P2093

Aurélie Petitfils

http://www.w3.org/2001/XMLSchema#string

Claire Vautravers Dewas

http://www.w3.org/2001/XMLSchema#string

Cécile Dalban

http://www.w3.org/2001/XMLSchema#string

Cédric Khoury

http://www.w3.org/2001/XMLSchema#string

Etienne Martin

http://www.w3.org/2001/XMLSchema#string

Gilles Créhange

http://www.w3.org/2001/XMLSchema#string

Gilles Truc

http://www.w3.org/2001/XMLSchema#string

Karine Peignaux

http://www.w3.org/2001/XMLSchema#string

Philippe Maingon

http://www.w3.org/2001/XMLSchema#string

Sylvain Dewas

http://www.w3.org/2001/XMLSchema#string

P2860

Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.

Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Time-dose considerations in the treatment of anal cancer.

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and

P2888

1748-717x-7-201

P304

201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-7-201

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233797558

http://www.w3.org/2001/XMLSchema#string

P6179

1018745575

http://www.w3.org/2001/XMLSchema#string

P698

23190693

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

3576273

http://www.w3.org/2001/XMLSchema#string